Danazol PHARMALOGY, development,formula,treatment,news,Marketing,medicalTaj Pharmaceuticals Ltd. API :: [TAJ GROUP] Danazol_PHARMALOGY, active pharmaceutical ingredients, api pharma, active pharmaceutical ingredient, api pharmaceuticals, active pharma, API India, active pharmaceuticals, active pharmaceuticals india, active pharma India

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Danazol Taj PharmaCeuticals

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Danazol Manufacturers in India Suppliers Danazol Exporters Distributors Danazol api active pharmaceuticals ingredients Danazol manufacturers Side Effects bulk drugs raw material Danazol companies Side Effects Importers Danazol Danazol Exporters Danazol exporters FDA Danazol DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Danazol manufacturing pharmaceutical drugs pharmaceutical intermediates Danazol pharmaceutical chemicals pharmaceutical raw materials Danazol active pharmaceutical ingredients Danazol committee active pharmaceutical ingredients manufacturer Danazol Active Pharmaceutical Ingredients manufacturer Danazol exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Danazol, Danazol manufacturer India, Danazol product, Danazol products, Api preparation, Certificate of Analysis API manufacturer product, Danazol anti ulcer product, Certificate of Origin COA Danazol COS Danazol, pharmaceutical generic, pharmaceutical drug, medical, Danazol pharma healthcare, pharma patents, contract MSDS manufacturing Trader Danazol pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Danazol expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Danazol DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Danazol ingredients, api, HIV Danazol, tablets, capsules, syrup & protein Danazol powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Danazol gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Danazol WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

Danazol Img.

HOME >> API >> API List1 >> Danazol >> Pharmalogy

PHARMALOGY
Danazol CAS Number 17230-88-5

Danazol suppresses the pituitary-ovarian axis. This suppression is probably a combination of depressed hypothalamic-pituitary response to lowered estrogen production, the alteration of sex steroid metabolism, and interaction of Danazol with sex hormone receptors. The only other demonstrable hormonal effect is weak androgenic activity. Danazol depresses the output of both follicle-stimulating hormone (FSH) and luteinizing hormone (LH).

Recent evidence suggests a direct inhibitory effect at gonadal sites and a binding of Danazol to receptors of gonadal steroids at target organs. In addition, Danazol has been shown to significantly decrease IgG, IgM and IgA levels, as well as phospholipid and IgG isotope autoantibodies in patients with endometriosis and associated elevations of autoantibodies, suggesting this could be another mechanism by which it facilitates regression of the disease.

Bioavailability studies indicate that blood levels do not increase proportionally with increases in the administered dose. When the dose of Danazol is doubled the increase in plasma levels is only about 35% to 40%.

Separate single dosing of 100 mg and 200 mg capsules of Danazol to female volunteers showed that both the extent of availability and the maximum plasma concentration increased by three-to-four fold, respectively, following a meal ( > 30 grams of fat), when compared to the fasted state. Further, food also delayed mean time to peak concentration of Danazol by about 30 minutes.

In the treatment of endometriosis, Danazol alters the normal and ectopic endometrial tissue so that it becomes inactive and atrophic. Complete resolution of endometrial lesions occurs in the majority of cases.

Changes in vaginal cytology and cervical mucus reflect the suppressive effect of Danazol on the pituitary-ovarian axis.

In the treatment of fibrocystic breast disease, Danazol usually produces partial to complete disappearance of nodularity and complete relief of pain and tenderness. Changes in the menstrual pattern may occur.

Generally, the pituitary-suppressive action of Danazol is reversible. Ovulation and cyclic bleeding usually return within 60 to 90 days when therapy with Danazol is discontinued.

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE

SIDE EFFECTS

PRECAUTIONS

INTERACTION

PHARMALOGY >>

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Api Manufacturing At Taj

Acamprosate Calcium	Clomipramine Hcl	Alendronate Sodium	Clonazepam	Amitriptyline	Clopidogrel Bisulfate	Anastrozole	Danazol	Atomoxetine Hcl	Desloratadine	Balsalazide
Desmopressin Monoacetate	Bicalutamide	Divalproex Sodium	Budesonide	Dobutamine Hcl	Bupropion Hcl	Donepezil	Calcitonin	Dothiepin Hcl	Capecitabine	Entacapone
Carbamazepine	Eptifibatide	Carboplatin	Escitalopram HBr	Carisoprodol	Eszopiclone	Carvedilol	Finasteride	Cefuroxime Axetil	Flurbiprofen	Cisplatin
Fluticasone Propionate	Citalopram Hbr	Fluvoxamine Maleate	Fosphenytoin Sodium

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.